90%Confidence
0Views
FDASource
2026-05-26Date
Summary
Ascend Laboratories' recall of metoprolol succinate tablets due to failed dissolution specifications may disrupt supply for hypertension patients, benefiting alternative manufacturers. The recall highlights manufacturing risks at Alkem Laboratories, which could affect Ascend's reputation and future contracts.
Actionable: Evaluate alternative suppliers for metoprolol succinate and review exposure to Ascend Laboratories' products.
AI Confidence: 90%
Data Points
firmAscend Laboratories, LLC
classificationClass II
statusOngoing
distributionU.S. Nationwide
productAscend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distrib
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now